"From (address)"|"From (display)"|"Sent on behalf of (address)"|"Date Sent"|"Subject"|"Body"|"Body HTML"
|"Monica Gerson"||"6/18/2014 9:16:29 AM"|"Benzinga's Top Initiations"|"Analysts at JMP Securities initiated coverage on shares of Compugen (NASDAQ: CGEN <http://www.benzinga.com/stock/cgen#NASDAQ> ) with a ìmarket outperformî rating. The target price for Compugen is set to $14. Compugen's shares closed at $9.06 yesterday.

Wedbush initiated coverage on shares of Five Below (NASDAQ: 

 <http://feeds.feedburner.com/~r/benzinga/analyst-ratings/~4/bJzixL9BEWg> 


View article... <http://feeds.benzinga.com/~r/benzinga/analyst-ratings/~3/bJzixL9BEWg/benzingas-top-initiations> 

"|"<html><head><base href=""http://feeds.benzinga.com/benzinga/analyst-ratings?format=xml""></head><style><!-- body {font-family:""Calibri"";} --></style><body><table><tr><td><p>Analysts at JMP Securities initiated coverage on shares of Compugen (NASDAQ: <a class=""ticker"" href=""http://www.benzinga.com/stock/cgen#NASDAQ"">CGEN</a>) with a ‚Äúmarket outperform‚Äù rating. The target price for Compugen is set to $14. Compugen&#039;s shares closed at $9.06 yesterday.</p> <p>Wedbush initiated coverage on shares of Five Below (NASDAQ: <a ...</p><img src=""http://feeds.feedburner.com/~r/benzinga/analyst-ratings/~4/bJzixL9BEWg"" height=""1"" width=""1""/></td></tr></table><p><BR/><A HREF=""http://feeds.benzinga.com/~r/benzinga/analyst-ratings/~3/bJzixL9BEWg/benzingas-top-initiations"">View article...</A></p></body></html>"
|"Eric Niederer"||"6/18/2014 8:59:21 AM"|"UPDATE: Morgan Stanley Initiates Coverage On Garmin"|"In a note released Wednesday morning Morgan Stanley analyst James Faucette initiated coverage on Garmin (NASDAQ: GRMN <http://www.benzinga.com/stock/grmn#NASDAQ> ) with an Underweight rating and announced a $52 price target.

Faucette began, ""Continued success is priced into the stock and we see little ...

 <http://feeds.feedburner.com/~r/benzinga/analyst-ratings/~4/HVvq7NI3EU4> 


View article... <http://feeds.benzinga.com/~r/benzinga/analyst-ratings/~3/HVvq7NI3EU4/update-morgan-stanley-initiates-coverage-on-garmin> 

"|"<html><head><base href=""http://feeds.benzinga.com/benzinga/analyst-ratings?format=xml""></head><style><!-- body {font-family:""Calibri"";} --></style><body><table><tr><td><p>  In a note released Wednesday morning Morgan Stanley analyst James Faucette initiated coverage on <strong>Garmin </strong>(NASDAQ: <a class=""ticker"" href=""http://www.benzinga.com/stock/grmn#NASDAQ"">GRMN</a>) with an Underweight rating and announced a $52 price target.</p> <p>  Faucette began, &quot;Continued success is priced into the stock and we see little ...</p><img src=""http://feeds.feedburner.com/~r/benzinga/analyst-ratings/~4/HVvq7NI3EU4"" height=""1"" width=""1""/></td></tr></table><p><BR/><A HREF=""http://feeds.benzinga.com/~r/benzinga/analyst-ratings/~3/HVvq7NI3EU4/update-morgan-stanley-initiates-coverage-on-garmin"">View article...</A></p></body></html>"
|"Erika Janowicz"||"6/18/2014 8:56:42 AM"|"Shire Shares Trend Higher On SunTrust's Note Of Possible Allergan Bid"|"Shares of Shire plc (NASDAQ: SHPG <http://www.benzinga.com/stock/shpg#NASDAQ> ) jumped 2.2 percent in Wednesday's pre-market following a SunTrust note suggesting that Allergan could bid for the pharmaceutical company.

SunTrust analyst John T. Boris reported that Allergan's bid for Shire would be ìmore attractiveî than Valeant's proposal. The analyst noted Allegan's bid ìallows more of an upsideî without traders holding the risky ...

 <http://feeds.feedburner.com/~r/benzinga/analyst-ratings/~4/tGBNY3ytxWw> 


View article... <http://feeds.benzinga.com/~r/benzinga/analyst-ratings/~3/tGBNY3ytxWw/shire-shares-trend-higher-on-suntrusts-note-of-possible-> 

"|"<html><head><base href=""http://feeds.benzinga.com/benzinga/analyst-ratings?format=xml""></head><style><!-- body {font-family:""Calibri"";} --></style><body><table><tr><td><p>Shares of <b>Shire plc</b> (NASDAQ: <a class=""ticker"" href=""http://www.benzinga.com/stock/shpg#NASDAQ"">SHPG</a>) jumped 2.2 percent in Wednesday&#039;s pre-market following a SunTrust note suggesting that <b>Allergan</b> could bid for the pharmaceutical company.</p> <p>SunTrust analyst John T. Boris reported that Allergan&#039;s bid for Shire would be ‚Äúmore attractive‚Äù than Valeant&#039;s proposal. The analyst noted Allegan&#039;s bid ‚Äúallows more of an upside‚Äù without traders holding the risky ...</p><img src=""http://feeds.feedburner.com/~r/benzinga/analyst-ratings/~4/tGBNY3ytxWw"" height=""1"" width=""1""/></td></tr></table><p><BR/><A HREF=""http://feeds.benzinga.com/~r/benzinga/analyst-ratings/~3/tGBNY3ytxWw/shire-shares-trend-higher-on-suntrusts-note-of-possible-"">View article...</A></p></body></html>"
|"Luke Jacobi"||"6/18/2014 8:32:42 AM"|"Riverbed Technology Unmoved By Morgan Stanley Initiation"|"Morgan Stanley sees upside in Riverbed Technology (NASDAQ: RVBD <http://www.benzinga.com/stock/rvbd#NASDAQ> ), but initiated the stock at Equal-weight.

Analyst James Faucette describes one of his key concerns, ìWith its core WAN optimization market growth down to ~6%, expanding the addressable market is critical, and we believe Riverbed's unified vision ...

 <http://feeds.feedburner.com/~r/benzinga/analyst-ratings/~4/NRjbHthen9s> 


View article... <http://feeds.benzinga.com/~r/benzinga/analyst-ratings/~3/NRjbHthen9s/riverbed-technology-unmoved-by-morgan-stanley-initiation> 

"|"<html><head><base href=""http://feeds.benzinga.com/benzinga/analyst-ratings?format=xml""></head><style><!-- body {font-family:""Calibri"";} --></style><body><table><tr><td><p>  Morgan Stanley sees upside in <strong>Riverbed Technology</strong> (NASDAQ: <a class=""ticker"" href=""http://www.benzinga.com/stock/rvbd#NASDAQ"">RVBD</a>), but initiated the stock at Equal-weight.</p> <p>  Analyst James Faucette describes one of his key concerns, &ldquo;With its core WAN optimization market growth down to ~6%, expanding the addressable market is critical, and we believe Riverbed&#39;s unified vision ...</p><img src=""http://feeds.feedburner.com/~r/benzinga/analyst-ratings/~4/NRjbHthen9s"" height=""1"" width=""1""/></td></tr></table><p><BR/><A HREF=""http://feeds.benzinga.com/~r/benzinga/analyst-ratings/~3/NRjbHthen9s/riverbed-technology-unmoved-by-morgan-stanley-initiation"">View article...</A></p></body></html>"
...</A></p></body></html>"
|"Monica Gerson"||"8/29/2014 7:35:35 AM"|"JP Morgan Upgrades AGCO To Neutral"|"Analysts at JP Morgan upgraded AGCO (NYSE: AGCO <http://www.benzinga.com/stock/agco#NYSE> ) from Underperform to Neutral. 

The target price for AGCO has ...

 <http://feeds.feedburner.com/~r/benzinga/analyst-ratings/upgrades/~4/z6Q0ihz5mzo> 


View article... <http://feeds.benzinga.com/~r/benzinga/analyst-ratings/upgrades/~3/z6Q0ihz5mzo/jp-morgan-upgrades-agco-to-neutral> 

"|"<html><head><base href=""http://feeds.benzinga.com/benzinga/analyst-ratings/upgrades?format=xml""></head><style><!-- body {font-family:""Calibri"";} --></style><body><table><tr><td><p>Analysts at JP Morgan upgraded AGCO (NYSE: <a class=""ticker"" href=""http://www.benzinga.com/stock/agco#NYSE"">AGCO</a>) from Underperform to Neutral. </p> <p>The target price for AGCO has ...</p><img src=""http://feeds.feedburner.com/~r/benzinga/analyst-ratings/upgrades/~4/z6Q0ihz5mzo"" height=""1"" width=""1""/></td></tr></table><p><BR/><A HREF=""http://feeds.benzinga.com/~r/benzinga/analyst-ratings/upgrades/~3/z6Q0ihz5mzo/jp-morgan-upgrades-agco-to-neutral"">View article...</A></p></body></html>"